Director Rothbaum Reports a $26.5 Million IOVA Purchase

JC Parets
September 18, 2023

From the Desk of Steve Strazza and Alfonso Depablos

The most significant insider purchase on today's list comes from Wayne P. Rothbaum, director of Iovance Biotherapeutics $IOVA.

Rothbaum declared a $26.5 million IOVA purchase in a Form 4 filing.

Great Point Partners LLC filed a 13G for UroGen Pharma Ltd $URGN revealing an initial stake of 8.51%.

Here’s The Hot List, with data through September 15, 2023:

In another Form 4, director Jonathan Kraft reported a purchase of $507,650 in TKO Group Holdings $TKO.

There was also insider activity in ChargePoint Holdings $CHPT and Victoria's Secret & Co $VSCO.

In the options market, there was bullish flow in ADT Inc $ADT, Nordic American Tankers Limited $NAT, and Viking Therapeutics Inc $VKTX.

Stay tuned. We'll be back on Tuesday with more insider activity.

If you want these insider transactions e-mailed to you every morning, click here to sign up for The Hot Corner.

And please reach out with any questions. We love hearing from you!

All Star Charts Team

Filed Under